Patent · US Active

Physiologically balanced injectable formulations of fosnetupitant

US11529362B2 · kind B2 · utility

0Cited by

1References

28Claims

0Family size

Assignee

Helsinn Healthcare SA · CH

Inventors

Alessio Venturini · Varese, IT
Roberta Cannella · Varese, IT

Key dates

Filing date	Mar 13, 2020
Grant date	Dec 20, 2022
Priority date	—
Expiry date	May 26, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P1/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Injectable dosages and formulations of fosnetupitant and pharmaceutically acceptable salts thereof are provided that are efficacious, chemically stable and physiologically balanced for safety and efficacy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.